The Japanese team successfully locked the substance in the blood that can determine fatty liver
October 26, 2018 Source: World Wide Web
Window._bd_share_config={ "common":{ "bdSnsKey":{ },"bdText":"","bdMini":"2","bdMiniList":false,"bdPic":"","bdStyle":" 0","bdSize":"16"},"share":{ }};with(document)0[(getElementsByTagName('head')[0]||body).appendChild(createElement('script')) .src='http://bdimg.share.baidu.com/static/api/js/share.js?v=89860593.js?cdnversion='+~(-new Date()/36e5)];According to a report by the Kyodo News Agency on October 26, St. Luke International University in Tokyo, Japan and Shimadzu Corporation in Kyoto announced that "Non-alcoholic fatty liver disease" (NAFLD), which is common in obesity and diabetes, has been successful. The substance in the blood that can be used to determine whether or not the disease is locked is locked.
This result allows people to find out early through physical examination, which may help prevent progression to cirrhosis or liver cancer. Shimadzu is striving to achieve clinical applications by 2020.
NAFLD is a disease that accumulates fat in the liver even if the amount of alcohol consumed is small. If it develops, it may become liver cancer. Some people point out that the cause is related to lifestyle-related diseases, and Japan is considered to have more than 10 million patients. Ultrasound and liver biopsy are required for diagnosis, and troublesome and expensive costs become a problem.
The blood of 3733 people who received a precise physical examination at the St. Luke International Hospital from 2015 to 2016 was sampled and analyzed. As a result, it was found that the amount of 70 substances such as "glutamic acid" in the blood of 826 patients diagnosed with NAFLD was different from that of healthy people.
Monkfish-Sliced,Monkfish-Fillets,Monkfish Tails With Skinless,Monkfish Tails With Skin-On
GOLD STAR FISHERY ZHOUSHAN CO.,LTD. , https://www.goldstar-aquatic.com